CBAV.MC CLINICA BAVIERA S.A.

Healthcare · Diagnostics & Research

5 · Fair Momentum 10.0 · Strong At risk

59.60

+0.00%

About the company

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

Website

2.63%

54.70%

1.57

955.2M

20.77

2.87

52.42

52-week range

59.6

low 40.1 high 62.0

Dividend deep dive

CLINICA BAVIERA S.A., operating in Diagnostics & Research within the Healthcare sector, currently offers a dividend yield of 2.74% EUR. This yield sits near the lower end of its 5-year historical range, which spans from 2.54% to 5.11% EUR. Yield Theory suggests the current valuation is fair. The company generated an EBITDA of 82,770,864 EUR.

Dividend history

The company has a dividend streak of 0 years, indicating inconsistency in annual increases. Its 3-year dividend CAGR stands at 44.99%, though a 5-year CAGR figure is not available. Dividends are paid annually, typically in June and July. Historic payments include 0.10 EUR in 2013, 0.28 EUR in 2014, 0.11 EUR in 2015, 0.315 EUR in 2016, 0.22 EUR in 2017, 0.48 EUR in 2018, 0.58 EUR in 2019, 0.526 EUR in 2021, 0.515 EUR in 2022, 0.80 EUR in 2023, and projected 1.57 EUR for 2024 and 2025.